Effects of propofol on cyclic strain-induced endothelin-1 expression in human umbilical vein endothelial cells

Anesthesiology

Volumn 110, Issue 1, 2009, Pages 74-80

  Cheng, Tzu Hurng ^a   Chen, Jin Jer ^b   Chen, Cheng Hsien ^c   Wong, Kar Lok ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; KT 5823; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRATE; NITRIC OXIDE; NITRITE; PROPOFOL; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MECHANICAL STRESS; NORTHERN BLOTTING; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIN-1; GENE EXPRESSION REGULATION; HUMANS; PROPOFOL; REACTIVE OXYGEN SPECIES; STRESS, MECHANICAL; UMBILICAL VEINS;

EID: 58749092199     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318190b51c     Document Type: Article

References (41)

1. Hutchens MP, Memtsoudis S, Sadovnikoff N: Propofol for sedation in neurointensive care. Neurocritical Care 2006; 4:54-62
2. Moos DD: Propofol. Gastroenterol Nurs 2006; 29:176-8
3. Marik PE: Propofol: Therapeutic indications and side-effects. Curr Pharm Des 2004; 10:3639-49
4. Bodelsson G, Sandstrom K, Wallerstedt SM, Hidestal J, Tornebrandt K, Bodelsson M: Effects of propofol on substance P-induced relaxation in isolated human omental arteries and veins. Eur J Anaesth 2000; 17:720-8
5. Horibe M, Ogawa K, Sohn JT, Murray PA: Propofol attenuates acetylcholineinduced pulmonary vasorelaxation: Role of nitric oxide and endothelium-derived hyperpolarizing factors. Anesthesiology 2000; 93:447-55
6. Park KW, Dai HB, Lowenstein E, Sellke FW: Propofol-associated dilation of rat distal coronary arteries is mediated by multiple substances, including endothelium- derived nitric oxide. Anesth Analg 1995; 81:1191-6
7. Corcoran TB, O'Shea A, Engel A, Shorten GD: The influence of propofol on P-selectin expression and nitric oxide production in re-oxygenated human umbilical vein endothelial cells. Acta Anaesthesiol Scand 2006; 50:348-54
8. Marik PE: Propofol: An immunomodulating agent. Pharmacother Suppl 2005; 25:S28-33
9. Gielen S, Schuler G, Hambrecht R: Exercise training in coronary artery disease and coronary vasomotion. Circulation 2001; 103:E1-6
10. Gewaltig MT, Kojda G: Vasoprotection by nitric oxide: Mechanisms and therapeutic potential. Cardiovasc Res 2002; 55:250-60
11. Schiffrin EL: Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens Suppl 2001; 14:S83-89
12. Mundhenke M, Schwartzkopff B, Kostering M, Deska U, Klein RM, Strauer BE: Endogenous plasma endothelin concentrations and coronary circulation in patients with mild dilated cardiomyopathy. Heart 1999; 81:278-84
13. Bohm F, Pernow J: The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 2007; 76:8-18
14. Tonnessen T, Giaid A, Saleh D, Naess PA, Yanagisawa M, Christensen G: Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res 1995; 76:767-72
15. Pernow J, Wang QD: Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res 1997; 33:518-26
16. Webb DJ, Monge JC, Rabelink TJ, Yanagisawa M: Endothelin: New discoveries and rapid progress in the clinic. Trends Pharmacol Sci 1998; 19:5-8
17. Koller A: Signaling pathways of mechanotransduction in arteriolar endothelium and smooth muscle cells in hypertension. Microcirculation 2002; 9:277-94
18. Witztum JL: The oxidation hypothesis of atherosclerosis. Lancet 1994; 344:793-5
19. Drexler H: Endothelial dysfunction: Clinical implications. Prog Cardiovasc Dis 1997; 39:287-324
20. Zafari AM, Ushio-Fukai M, Minieri CA, Akers M, Lassegue B, Griendling KK: Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. Antioxid Redox Signal 1999; 1:167-79
21. Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ, Wang DL: Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 1997; 81:1-7
22. Liu JC, Chen JJ, Chan P, Cheng CF, Cheng TH: Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 2003; 42:1198-205
23. Cheng TH, Shih NL, Chen SY, Loh SH, Cheng PY, Tsai CS, Liu SH, Wang DL, Chen JJ: Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. J Mol Cell Cardiol 2001; 33:1805-14
24. Ziegler T, Bouzourene K, Harrison VJ, Brunner HR, Hayoz D: Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. Arterioscler Thromb Vasc Biol 1998; 18:686-92
25. Wang DL, Wung BS, Peng YC, Wang JJ: Mechanical strain increases endothelin-1 gene expression via protein kinase C pathway in human endothelial cells. J Cell Physiol 1995; 163:400-6
26. Wong KL, Lin JW, Liu JC, Yang HY, Kao PF, Chen CH, Loh SH, Chiu WT, Cheng TH, Lin JG, Hong HJ: Antiproliferative effect of isosteviol on angiotensin II-treated rat aortic smooth muscle cells. Pharmacology 2006; 76:163-9
27. Wong KL, Wu KC, Wu RS, Chou YH, Cheng TH, Hong HJ: Tetramethylpyrazine inhibits angiotensin-II increased NAD(P)H oxidase activity and subsequent proliferation in rat aortic smooth muscle cells. Am J Chin Med 2007; 35:1021-35
28. So EC, Wong KL, Huang TC, Tsai SC, Liu CF: Tetramethylpyrazine protects mice against thioacetamide-induced acute hepatotoxicity. J Biomed Sci 2002; 9:410-4
29. Fraga CG, Martino VS, Ferraro GE, Coussio JD, Boveris A: Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem Pharmacol 1987; 36:717-20
30. Wilmsen PK, Spada DS, Salvador M: Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. J Agric Food Chem 2005; 53: 4757-61
31. McDermott BJ, McWilliams S, Smyth K, Kelso EJ, Spiers JP, Zhao Y, Bell D, Mirakhur RK: Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity. J Mol Cell Cardiol 2007; 42:600-8
32. Kim JY, Jung KJ, Choi JS, Chung HY: Hesperetin: A potent antioxidant against peroxynitrite. Free Radic Res 2004; 38:761-9
33. Luo T, Xia Z, Ansley DM, Ouyang J, Granville DJ, Li Y, Xia ZY, Zhou QS, Liu XY: Propofol dose-dependently reduces tumor necrosis factor-alpha-induced human umbilical vein endothelial cell apoptosis: Effects on Bcl-2 and Bax expression and nitric oxide generation. Anesth Analg 2005; 100:1653-9
34. Petros AJ, Bogle RG, Pearson JD: Propofol stimulates nitric oxide release from cultured porcine aortic endothelial cells. Br J Pharmacol 1993; 109:6-7
35. Ohkita M, Takaoka M, Shiota Y, Nojiri R, Matsumura Y: Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. Clin Sci (Lond) Suppl 2002; 103:S68-71
36. Smith AP, Demoncheaux EA, Higenbottam TW: Nitric oxide gas decreases endothelin-1 mRNA in cultured pulmonary artery endothelial cells. Nitric Oxide 2002; 6:153-9
37. Mitsutomi N, Akashi C, Odagiri J, Matsumura Y: Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. Eur J Pharmacol 1999; 364:65-73
38. Dimmeler S, Zeiher AM: Nitric oxide-an endothelial cell survival factor. Cell Death Differ 1999; 6:964-8
39. Ho FM, Lin WW, Chen BC, Chao CM, Yang CR, Lin LY, Lai CC, Liu SH, Liau CS: High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/ Akt/eNOS pathway. Cell Signal 2006; 18:391-9
40. Abdallah Y, Schafer C: Insulin: An overall cardiovascular protector? [Editorial]. Cardiovasc Res 2006; 69:4-6
41. Wang B, Luo T, Chen D, Ansley DM: Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells. Anesth Analg 2007; 105:1027-33